Get startedLog in
    Picture of Biotechnology Assets SA logo

    BST — Biotechnology Assets SA Cashflow Statement

    0.000.00%
    es flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Biotechnology Assets SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

    C2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Depreciation
    Amortisation
    Non-Cash Items-7.01-7.010.580.0740.158
    Discontinued Operations
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-10.213.6-4.11-2.24-2.58
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-15.28.79-1.5-0.0170.048
    Capital Expenditures-7.48-0.392-0.661-2.12-0.326
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items—45.200—
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Sale of Intangible Assets
    Other Investing Cash Flow
    Cash from Investing Activities-7.4844.8-0.661-2.12-0.326
    Financing Cash Flow Items0.9860.085—-0.06-0.37
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities23.5-57.83.281.15-0.061
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash0.818-4.211.12-0.985-0.339